Literature DB >> 20882530

Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.

Qirui Hu1, Amy M Friedrich, Lincoln V Johnson, Dennis O Clegg.   

Abstract

Induced pluripotent stem (iPS) cells have been generated from a variety of somatic cell types via introduction of transcription factors that mediate pluripotency. However, it is unknown that all cell types can be reprogrammed and whether the origin of the parental cell ultimately determines the behavior of the resultant iPS cell line. We sought to determine whether human retinal-pigmented epithelial (RPE) cells could be reprogrammed, and to test the hypothesis that reprogrammed cells retain a "memory" of their origin in terms of propensity for differentiation. We reprogrammed primary fetal RPE cells via lentiviral expression of OCT4, SOX2, LIN28, and Nanog. The iPS cell lines derived from RPE exhibited morphologies similar to human embryonic stem cells and other iPS cell lines, expressed stem cell markers, and formed teratomas-containing derivatives of all three germ layers. To test whether these iPS cells retained epigenetic imprints from the parental RPE cells, we analyzed their propensity for spontaneous differentiation back into RPE after removal of FGF2. We found that some, but not all, iPS lines exhibited a marked preference for redifferentiation into RPE. Our results show that RPE cells can be reprogrammed to pluripotency, and suggest that they often retain a memory of their previous state of differentiation.
Copyright © 2010 AlphaMed Press.

Entities:  

Mesh:

Year:  2010        PMID: 20882530     DOI: 10.1002/stem.531

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  77 in total

Review 1.  Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors:  Sangho Lee; Young-Sup Yoon
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

2.  Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature.

Authors:  Huansheng Xu; B Alexander Yi; Hao Wu; Christoph Bock; Hongcang Gu; Kathy O Lui; Joo-Hye C Park; Ying Shao; Alyssa K Riley; Ibrahim J Domian; Erding Hu; Robert Willette; John Lepore; Alexander Meissner; Zhong Wang; Kenneth R Chien
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

Review 3.  Human induced pluripotent stem cells--from mechanisms to clinical applications.

Authors:  Katharina Drews; Justyna Jozefczuk; Alessandro Prigione; James Adjaye
Journal:  J Mol Med (Berl)       Date:  2012-05-30       Impact factor: 4.599

4.  Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.

Authors:  Kim Hynes; Danijela Menicanin; Krzysztof Mrozik; Stan Gronthos; P Mark Bartold
Journal:  Stem Cells Dev       Date:  2014-02-07       Impact factor: 3.272

Review 5.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

6.  Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.

Authors:  Dhruv Sareen; Mehrnoosh Saghizadeh; Loren Ornelas; Michael A Winkler; Kavita Narwani; Anais Sahabian; Vincent A Funari; Jie Tang; Lindsay Spurka; Vasu Punj; Ezra Maguen; Yaron S Rabinowitz; Clive N Svendsen; Alexander V Ljubimov
Journal:  Stem Cells Transl Med       Date:  2014-07-28       Impact factor: 6.940

7.  Effects of erythropoietin in murine-induced pluripotent cell-derived panneural progenitor cells.

Authors:  Nils Offen; Johannes Flemming; Hares Kamawal; Ruhel Ahmad; Wanja Wolber; Christian Geis; Holm Zaehres; Hans R Schöler; Hannelore Ehrenreich; Albrecht M Müller; Anna-Leena Sirén
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

Review 8.  Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells.

Authors:  Orit Harari-Steinberg; Oren Pleniceanu; Benjamin Dekel
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

Review 9.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

10.  A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.

Authors:  Julien Maruotti; Karl Wahlin; David Gorrell; Imran Bhutto; Gerard Lutty; Donald J Zack
Journal:  Stem Cells Transl Med       Date:  2013-04-12       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.